血液透析用血管アクセスデバイス市場：市場規模（セグメント別）、シェア、規制、償還、手技、予測（～2033年）

腎臓が機能しなくなると、体内に水分が貯留し、有害な老廃物が蓄積します。末期腎不全（ESRD）の患者には、機能不全に陥った腎臓の働きを補う治療が必要です。

慢性腎臓病（CKD）は、一定期間にわたって腎機能が低下する疾患です。糸球体濾過量が毎分60ミリリットル未満の状態が3ヵ月以上続くか、尿中アルブミン／クレアチニン比がクレアチニン1グラム（g）に対してアルブミンが30ミリグラム（mg）を超える（30mg／g）場合にCKDとなります。

急性腎障害とは、腎臓の機能が突然、一時的に、時には致命的に低下することです。

当レポートは、世界の血液透析用血管アクセスデバイス市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている血液透析用血管アクセスデバイスと競合情勢

• 主要な業界動向の洞察
• 血液透析用血管アクセスデバイスのセグメント別総市場収益と競合情勢
• 台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 血液透析用血管アクセスデバイス市場のSWOT分析
• 血液透析用血管アクセスデバイス市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Vascular Access Devices for Hemodialysis Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Nephrology and Urology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Vascular Access Devices for Hemodialysis market for the year 2020 and beyond.

End-Stage Renal Disease (ESRD):

Total and permanent kidney failure. When the kidneys fail, the body retains fluid. Harmful wastes build up. A person with ESRD needs treatment to replace the work of the failed kidneys.

Chronic Kidney Disease (CKD):

Any condition that causes reduced kidney function over a period of time. CKD is present when a patient's glomerular filtration rate remains below 60 milliliters per minute for more than 3 months or when a patient's urine albumin-to-creatinine ratio is over 30 milligrams (mg) of albumin for each gram (g) of creatinine (30 mg/g).

Acute Kidney Injury:

Sudden, temporary, and sometimes fatal loss of kidney function.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Vascular Access Devices for Hemodialysis and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Vascular Access Devices for Hemodialysis market revenue by segment and market outlooks from

2015- 2033.

• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Vascular Access Devices for Hemodialysis.
• Competitive dynamics insights and trends provided for Vascular Access Devices for Hemodialysis market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Fresenius SE & Co KGaA, Becton Dickinson and Co, Baxter International Inc, Medtronic Plc, B. Braun Melsungen AG, W. L. Gore & Associates Inc, NIPRO Corp, and others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Vascular Access Devices for Hemodialysis market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Vascular Access Devices for Hemodialysis market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Vascular Access Devices for Hemodialysis market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Vascular Access Devices for Hemodialysis market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Vascular Access Devices for Hemodialysis market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Not Applicable